Form 4 Tracker
Royalty Pharma plc
RPRX

19 insider filings · Latest: May 6, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Apr 28, 2026Apr 30 9:54 PMTerrance P. CoyneEVP & CFO
Sale
34,791$49.78$1.7M40,136(I)

View →

Apr 28, 2026Apr 28 9:00 PMTerrance Coyne
Proposed Sale
34,791$49.54$1.7M

View →

Apr 1, 2026Apr 2 9:58 PMTerrance P. CoyneEVP & CFO
Sale
34,791$48.33$1.7M32,916(I)

View →

Apr 1, 2026Apr 1 8:55 PMTerrance Coyne
Proposed Sale
34,791$48.49$1.7M

View →

Mar 23, 2026Mar 25 9:05 PMTerrance P. CoyneEVP & CFO
Sale
34,791$45.53$1.6M43,886(I)

View →

Mar 23, 2026Mar 23 8:43 PMTerrance Coyne
Proposed Sale
34,791$45.61$1.6M

View →

Mar 19, 2026Mar 19 9:12 PMGeorge Lloyd
Proposed Sale
36,518$45.53$1.7M

View →

Mar 18, 2026Mar 18 10:02 PMGeorge Lloyd
Proposed Sale
100,462$45.79$4.6M

View →

Mar 2, 2026Mar 4 10:11 PMTerrance P. CoyneEVP & CFO
Sale
34,791$46.78$1.6M45,761(I)

View →

Mar 4, 2026Mar 4 9:52 PMGeorge Lloyd
Proposed Sale
136,980$47.43$6.5M

View →

Mar 2, 2026Mar 2 10:26 PMTerrance Coyne
Proposed Sale
34,791$47.47$1.7M

View →

Feb 23, 2026Feb 25 9:08 PMTerrance P. CoyneEVP & CFO
Sale
34,791$45.32$1.6M47,636(I)

View →

Feb 23, 2026Feb 23 10:06 PMTerrance Coyne
Proposed Sale
34,791$45.47$1.6M

View →

Feb 4, 2026Feb 4 10:07 PMTerrance P. CoyneEVP & CFO
Sale
20,163$43.29$872.9K22,885(I)

View →

Feb 3, 2026Feb 4 10:07 PMTerrance P. CoyneEVP & CFO
Sale
114,954$42.84$4.9M23,972(I)

View →

Feb 2, 2026Feb 4 10:07 PMTerrance P. CoyneEVP & CFO
Sale
108,424$42.08$4.6M30,167(I)

View →

Feb 3, 2026Feb 3 10:31 PMTerrance Coyne
Proposed Sale
135,117$42.97$5.8M

View →

Feb 2, 2026Feb 2 10:28 PMTerrance Coyne
Proposed Sale
108,424$42.36$4.6M

View →

Jan 30, 2026Feb 2 9:59 PMMarshall UristEVP, Research & Investments
Sale
20,000$41.09$821.8K0(I)

View →

Jan 23, 2026Jan 26 9:10 PMMarshall UristEVP, Research & Investments
Sale
20,000$40.26$805.1K20,000(I)

View →

Page 1 of 2

Next →

Stock Options & Derivatives

No transactions found.